tradingkey.logo
tradingkey.logo
Search

Abbott Laboratories

ABT
Add to Watchlist
91.790USD
+1.060+1.17%
Market hours ETQuotes delayed by 15 min
159.88BMarket Cap
25.47P/E TTM

Abbott Laboratories

91.790
+1.060+1.17%
View Detailed Chart
Intraday
1m
30m
1h
D
W
M
D

Today

+1.17%

5 Days

+6.36%

1 Month

+4.85%

6 Months

-26.80%

Year to Date

-26.74%

1 Year

-30.96%

TradingKey Stock Score of Abbott Laboratories

Currency: USD Updated: 2026-06-04

Key Insights

Abbott Laboratories's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 19 out of 203 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 118.40.In the medium term, the stock price is expected to trend down.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Abbott Laboratories's Score

Industry at a Glance

Industry Ranking
19 / 203
Overall Ranking
70 / 4581
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

38°C

Very Low
Very High
Neutral

Abbott Laboratories Highlights

StrengthsRisks

Abbott Laboratories is an American multinational health care and medical devices corporation headquartered in Abbott Park, Illinois. Founded in 1888 by Chicago physician Wallace Calvin Abbott, the company initially focused on formulating known drugs. Today, it offers medical devices, diagnostics, branded generic medications, and nutritional products. In 2013, Abbott separated its research-based pharmaceuticals division into AbbVie.

Abbott's product lineup includes Pedialyte, Similac, BinaxNOW, Ensure, Glucerna, ZonePerfect, FreeStyle Libre, i-STAT, and MitraClip.

Industry Leader
The company's revenue leads the industry, with the latest annual revenue totaling USD 44.33B.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 29.13%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 29.13%.
Fairly Valued
The company’s latest PE is 25.19, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 1.25B shares, decreasing 13.03% quarter-over-quarter.
Held by Private Capital
Star Investor Private Capital holds 2.90K shares of this stock.

Analyst Rating

Based on 30 analysts
Buy
Current Rating
118.402
Target Price
+36.11%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Abbott Laboratories Info

Abbott Laboratories is an American multinational health care and medical devices corporation headquartered in Abbott Park, Illinois. Founded in 1888 by Chicago physician Wallace Calvin Abbott, the company initially focused on formulating known drugs. Today, it offers medical devices, diagnostics, branded generic medications, and nutritional products. In 2013, Abbott separated its research-based pharmaceuticals division into AbbVie.

Abbott's product lineup includes Pedialyte, Similac, BinaxNOW, Ensure, Glucerna, ZonePerfect, FreeStyle Libre, i-STAT, and MitraClip.

Ticker SymbolABT
CompanyAbbott Laboratories
CEOFord (Robert B)
Websitehttps://www.abbott.com
KeyAI